Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline

December 20, 2023

https://www.globenewswire.com/news-release/2023/12/20/2799170/0/en/Absci-and-PrecisionLife-Announce-Strategic-R-D-Partnership-to-Jointly-Develop-AI-Enabled-Drug-Pipeline.html

Leading AI biologics and precision medicine innovators will harness technologies to build a diverse portfolio of novel drug treatments

With this partnership, Absci achieves 2023 outlook of ten new Active Programs signed for the year

Read more at globenewswire.com

Related news for (ABSI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.